The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Shares rally, retail surge drives silver to 8-year high

Mon, 01st Feb 2021 10:08

* Global stocks up 0.5%; S&P 500 futures up 1%

* Retail crowd turns gaze on silver, jumps to 8-year high

* Oil up 1%; Dollar index, Bund, T-bill yields steady

* Excess Money? https://tmsnrt.rs/2YpThUB

By Simon Jessop

LONDON, Feb 1 (Reuters) - Global shares bounced and silver
markets surged on Monday as retail investors expanded their
social-media fuelled battle against Wall Street to drive the
precious metal to an eight-year high.

Stock markets were roiled last week after a spike in retail
demand to buy the stocks most bet against by hedge funds drove
huge gains in companies such as GameStop Corp and
prompted fresh concern that COVID-19 monetary and fiscal support
measures were fuelling a market bubble.

With chatrooms abuzz with talk that silver was the new
target, silver-exposed stocks, funds and coins jumped, helping
push spot silver up more than 11%, with London-listed
miners up strongly, including Fresnillo, up 18%.

After falling 3.6% last week - its biggest weekly fall in
three months - the MSCI All-Country World Index
was up 0.5% in early deals, tracking overnight gains in Asia.

MSCI's broadest index of Asia-Pacific shares outside Japan
climbed 1.9% while Japan's Nikkei added
1.5% and Chinese blue chips rose 1.2% after the
country's central bank injected more cash into money markets.

Futures for the S&P 500 and NASDAQ, meanwhile,
both pointed to a stronger open on Wall Street, up around 1%.

While the retail battle versus Wall Street, coordinated over
online forums such as Reddit, created some systemic risks, the
bigger danger was in the tech sector, where some stocks had "eye
watering valuations", Deutsche Bank analyst Jim Reid said.

"Retail has in many parts driven such valuations in the last
10 months. If this pops the wider market will have bigger issues
than last week."

Gold followed silver higher, up 1% to $1,864 an ounce
, while oil also tracked the gains in other commodities,
with both Brent crude and its U.S. peer up around
1%.

While the stock market tussle continued to grab the
headlines, analysts cautioned the bigger concern was economic
momentum in the United States and Europe as coronavirus
lockdowns bite.

Indeed, two surveys from China showed factory activity
slowed in January as restrictions took a toll in some regions.
In the euro zone, manufacturing growth remained resilient at the
start of the year but the pace waned from December. Data from
Britain will be in focus later in the European session.

While the coronavirus vaccine rollout globally remains slow,
with concern about whether they will work on new COVID strains,
Europe was also bolstered by news that it would receive a
further 9 million doses from AstraZeneca in the first quarter.

"It is these considerations, not what is happening to a
video game retailer day to day, that has weighed on risk
assets," said John Briggs, global head of strategy at NatWest
Markets. "So much of the market's valuations, risk in
particular, is premised on the fact we can see a light at the
end of the COVID tunnel."

Higher yields combined with the more cautious market mood
have seen the safe-haven dollar steady above its recent lows.
The dollar index stood at 90.722, having bounced from a
trough of 89.206 hit early in January.

The euro, meanwhile, fell 0.3% to $1.2100, well off
its recent peak at $1.2349, while the pound was the biggest
gainer in the G10 group of currencies, up 0.3% on the day at
$1.3732..

With riskier markets bouncing, Italian government bond
yields fell 2-3 basis points across the curve.

German Bund yields, meanwhile, the benchmark for the euro
zone, remained anchored around -0.51% on Monday, tracking U.S.
Treasury yields that also remained unchanged..

(Additional reporting by Abhinav Ramnarayan and Ritvik
Carvalho; Editing by Toby Chopra, William Maclean)

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.